Literature DB >> 29339358

Family History of Cancer and Risk of Biliary Tract Cancers: Results from the Biliary Tract Cancers Pooling Project.

Alison L Van Dyke1, Margaret S Langhamer2,3, Bin Zhu2, Ruth M Pfeiffer2, Demetrius Albanes2, Gabriella Andreotti2, Laura E Beane Freeman2, Andrew T Chan4, Neal D Freedman2, Susan M Gapstur3,5, Graham G Giles6,7, Francine Grodstein8, Linda M Liao2, Juhua Luo9, Roger L Milne6,7, Kristine R Monroe10, Marian L Neuhouser11, Jenny N Poynter12, Mark P Purdue2, Kim Robien13, Catherine Schairer2, Rashmi Sinha2, Stephanie Weinstein2, Xuehong Zhang14, Jessica L Petrick2, Katherine A McGlynn2, Peter T Campbell5, Jill Koshiol2.   

Abstract

Background: Although some familial cancer syndromes include biliary tract cancers (BTCs; cancers of the gallbladder, intrahepatic and extrahepatic bile ducts, and ampulla of Vater), the few studies that have examined the relationships between family history of cancer (FHC) and BTCs have reported inconclusive findings. The objective of this study was to investigate the associations of FHC with risk of BTC in the Biliary Tract Cancers Pooling Project (BiTCaPP).
Methods: We used Cox proportional hazards regressions models to estimate HRs and 95% confidence intervals for associations between FHC (any, first-degree, in female relative, in male relative, relative with gastrointestinal cancer, and relative with hormonally related cancer) and BTC risk by anatomic site within the biliary tract, adjusting for sex and race/ethnicity. Sensitivity analyses were conducted that restricted to studies reporting cholecystectomy data and to people without a history of cholecystectomy.
Results: Data on FHC were available from 12 prospective studies within BiTCaPP, which collectively contributed 2,246 cases (729 gallbladder, 345 intrahepatic and 615 extrahepatic bile duct, and 385 ampulla of Vater cancers) with 21,706,107 person-years of follow-up. A marginal, inverse association between FHC and gallbladder cancer was driven to the null when analysis was restricted to studies reporting cholecystectomy data and to people without a history of cholecystectomy. FHC was not associated with risk of BTC at the other anatomic sites.Conclusions: These findings do not support an association between FHC and BTCs.Impact: In a study of 1.5 million people, FHC is not a risk factor for BTCs. Cancer Epidemiol Biomarkers Prev; 27(3); 348-51. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2018        PMID: 29339358      PMCID: PMC5835211          DOI: 10.1158/1055-9965.EPI-17-1003

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  8 in total

1.  Medical conditions, family history of cancer, and the risk of biliary tract cancers.

Authors:  Valentina Rosato; Cristina Bosetti; Luigino Dal Maso; Maurizio Montella; Diego Serraino; Eva Negri; Carlo La Vecchia
Journal:  Tumori       Date:  2015-08-04       Impact factor: 2.098

2.  An objective assessment of demography of gallbladder cancer.

Authors:  J Ram Kumar; Mallika Tewari; Arundhati Rai; Rohan Sinha; Sadhu C Mohapatra; Hari S Shukla
Journal:  J Surg Oncol       Date:  2006-06-15       Impact factor: 3.454

3.  Risk factors for gallbladder cancer: a case-control study.

Authors:  Kajal Jain; V Sreenivas; T Velpandian; Umesh Kapil; Pramod Kumar Garg
Journal:  Int J Cancer       Date:  2012-09-21       Impact factor: 7.396

4.  Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002.

Authors:  M T Goodman; Jennifer Yamamoto
Journal:  Cancer Causes Control       Date:  2007-01-30       Impact factor: 2.506

5.  Risk factors for cholangiocarcinoma in the lower part of Northeast Thailand: a hospital-based case-control study.

Authors:  Mereerat Manwong; Nopparat Songserm; Supannee Promthet; Keitaro Matsuo
Journal:  Asian Pac J Cancer Prev       Date:  2013

6.  Familial Risk of Biliary Tract Cancers: A Population-Based Study in Utah.

Authors:  N Jewel Samadder; Ken Robert Smith; Jathine Wong; Heidi Hanson; Kenneth Boucher; Randall W Burt; Michael Charlton; Kathryn R Byrne; Juan F Gallegos-Orozco; Cathryn Koptiuch; Karen Curtin
Journal:  Dig Dis Sci       Date:  2016-09-21       Impact factor: 3.199

7.  Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden.

Authors:  K Hemminki; X Li
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

8.  Hereditary pancreatic and hepatobiliary cancers.

Authors:  Ashraf Haddad; Gopal C Kowdley; Timothy M Pawlik; Steven C Cunningham
Journal:  Int J Surg Oncol       Date:  2011-06-28
  8 in total
  4 in total

1.  Anthropometric Risk Factors for Cancers of the Biliary Tract in the Biliary Tract Cancers Pooling Project.

Authors:  Sarah S Jackson; Alison L Van Dyke; Bin Zhu; Ruth M Pfeiffer; Jessica L Petrick; Hans-Olov Adami; Demetrius Albanes; Gabriella Andreotti; Laura E Beane Freeman; Amy Berrington de González; Julie E Buring; Andrew T Chan; Yu Chen; Gary E Fraser; Neal D Freedman; Yu-Tang Gao; Susan M Gapstur; J Michael Gaziano; Graham G Giles; Eric J Grant; Francine Grodstein; Patricia Hartge; Mazda Jenab; Cari M Kitahara; Synnove F Knutsen; Woon-Puay Koh; Susanna C Larsson; I-Min Lee; Linda M Liao; Juhua Luo; Emma E McGee; Roger L Milne; Kristine R Monroe; Marian L Neuhouser; Katie M O'Brien; Ulrike Peters; Jenny N Poynter; Mark P Purdue; Kim Robien; Dale P Sandler; Norie Sawada; Catherine Schairer; Howard D Sesso; Tracey G Simon; Rashmi Sinha; Rachael Z Stolzenberg-Solomon; Shoichiro Tsugane; Renwei Wang; Elisabete Weiderpass; Stephanie J Weinstein; Emily White; Alicja Wolk; Jian-Min Yuan; Anne Zeleniuch-Jacquotte; Xuehong Zhang; Katherine A McGlynn; Peter T Campbell; Jill Koshiol
Journal:  Cancer Res       Date:  2019-05-21       Impact factor: 12.701

2.  Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.

Authors:  Alison L Van Dyke; Meredith S Shiels; Gieira S Jones; Ruth M Pfeiffer; Jessica L Petrick; Jennifer L Beebe-Dimmer; Jill Koshiol
Journal:  Cancer       Date:  2019-01-15       Impact factor: 6.860

3.  SEOM clinical guidelines for pancreatic and biliary tract cancer (2020).

Authors:  Mª A Gómez-España; A F Montes; R Garcia-Carbonero; T M Mercadé; J Maurel; A M Martín; R Pazo-Cid; R Vera; A Carrato; J Feliu
Journal:  Clin Transl Oncol       Date:  2021-03-03       Impact factor: 3.405

Review 4.  Epidemiology of gallbladder cancer.

Authors:  Prashanth Rawla; Tagore Sunkara; Krishna Chaitanya Thandra; Adam Barsouk
Journal:  Clin Exp Hepatol       Date:  2019-05-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.